Burning Rock Biotech (BNR) Beginning Cash Balance (2019 - 2026)

Burning Rock Biotech (BNR) has reported Beginning Cash Balance for 8 consecutive years, with $69.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Beginning Cash Balance fell 3.07% year-over-year to $69.7 million; the TTM figure through Mar 2026 stood at $273.3 million (down 10.88% YoY), while the FY2025 annual figure was $74668.0, down 11.41% from the prior year.
• Beginning Cash Balance came in at $69.7 million for Q1 2026 at Burning Rock Biotech, up from $66.8 million in the prior quarter.
• The five-year high for Beginning Cash Balance was $227.0 million in Q1 2022, with the low at $63.9 million in Q3 2025.
• Average Beginning Cash Balance over 5 years is $111.1 million, with a median of $87.7 million recorded in 2024.
• Across the five-year window, Beginning Cash Balance tumbled 57.02% in 2023 and slipped 2.17% in 2025, its largest moves.
• Year by year, Beginning Cash Balance stood at $208.7 million in 2022, then sank by 57.02% to $89.7 million in 2023, then slipped by 23.89% to $68.3 million in 2024, then slipped by 2.17% to $66.8 million in 2025, then grew by 4.44% to $69.7 million in 2026.
• According to Business Quant data, Beginning Cash Balance over the past three periods registered $69.7 million, $66.8 million, and $63.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.